ResearcherNanjing Drum Tower HospitalActive in the last 2 years
Hexing Hang
Matched on ORCID iD 0000-0003-1329-4880; OpenAlex author ID A5090941260, A5158370829. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2024: 2 papers · 2025: 2 papers · 2026: 1 paper
Papers 5
- HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer. First author DOI 10.7150/ijbs.133139↗
- SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. Co-author DOI 10.1002/advs.202510071↗
- CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217713↗
- Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2024.216611↗
- Comparison of prognosis and postoperative morbidities between standard pancreaticoduodenectomy and the TRIANGLE technique for resectable pancreatic ductal aden… Co-author DOI 10.4240/wjgs.v16.i3.689↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yudong Qiu · 3 shared papers, 2024–2025 · strength 0.65
- Paper Comparison of prognosis and postoperative morbidities between standard pancreaticoduodenectomy and the TRIANGLE techniq… DOI 10.4240/wjgs.v16.i3.689↗
- Paper Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression. DOI 10.1016/j.canlet.2024.216611↗
- Paper SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. DOI 10.1002/advs.202510071↗
- Neng Tang · 3 shared papers, 2024–2025 · strength 0.60
- Paper Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression. DOI 10.1016/j.canlet.2024.216611↗
- Paper CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer. DOI 10.1016/j.canlet.2025.217713↗
- Paper SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. DOI 10.1002/advs.202510071↗
- Zhenghua Cai · 2 shared papers, 2024–2025 · strength 0.45
- Linxi Zhu · 2 shared papers, 2024–2025 · strength 0.40
- Jiatong Tang · 2 shared papers, 2025 · strength 0.39
- Chao Yan · 2 shared papers, 2025 · strength 0.39
- Hao Cheng · 2 shared papers, 2025 · strength 0.39
- Hao Cheng · 1 shared paper, 2026 · strength 0.30
- Yu Xie · 1 shared paper, 2026 · strength 0.30
- Hao Cheng · 1 shared paper, 2024 · strength 0.26
- Wangsen Cao · 1 shared paper, 2024 · strength 0.21
- Yixuan Zhang · 1 shared paper, 2025 · strength 0.20
- Wei Wei · 1 shared paper, 2025 · strength 0.20
- Yudong Qiu · 1 shared paper, 2025 · strength 0.20
- Qi Li · 1 shared paper, 2025 · strength 0.19
- Xiao Fu · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.